Oct 10 (Reuters) - Bristol-Myers Squibb Co ( BMY ):
* BRISTOL MYERS SQUIBB STRENGTHENS AND DIVERSIFIES CELL
THERAPY
PORTFOLIO WITH ACQUISITION OF ORBITAL THERAPEUTICS
* BRISTOL-MYERS SQUIBB CO ( BMY ) - BMS TO PAY $1.5 BILLION IN CASH
FOR
ORBITAL
Source text:
Further company coverage: